reference/24288659

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24288659

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	203
issn	1421-9794 0009-3157
issueIdentifier	4
pageRange	197-203
publicationName	Chemotherapy
startingPage	197
bibliographicCitation	Wang W, Huang J, Tao Y, Lyu X, Yang L, Wu D, Tian Y. Phase II and UGT1A1 Polymorphism Study of Two Different Irinotecan Dosages Combined with Cisplatin as First-Line Therapy for Advanced Gastric Cancer. Chemotherapy. 2016;61(4):197–203. doi: 10.1159/000442787. PMID: 26872008.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a27711cb164486174dde86a7dde938f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_827a57e584f78fd3b764607095689269 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_680cb451f6a995b37b96029f7ebdd90d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dec7e629a7ea2a17bfff872b02907c27 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3e110477084ac5ed1b966c056204494 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_482386e8f08914a497d24d33c80031d6
date	2016
identifier	https://pubmed.ncbi.nlm.nih.gov/26872008 https://doi.org/10.1159/000442787
isPartOf	https://portal.issn.org/resource/ISSN/0009-3157 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2914 https://portal.issn.org/resource/ISSN/1421-9794
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Phase II and UGT1A1 Polymorphism Study of Two Different Irinotecan Dosages Combined with Cisplatin as First-Line Therapy for Advanced Gastric Cancer
discusses	http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0003242 http://id.nlm.nih.gov/mesh/M0004505 http://id.nlm.nih.gov/mesh/M0147530 http://id.nlm.nih.gov/mesh/M0022213 http://id.nlm.nih.gov/mesh/M0376612
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D002945Q000627 http://id.nlm.nih.gov/mesh/D013274Q000188 http://id.nlm.nih.gov/mesh/D002166Q000031 http://id.nlm.nih.gov/mesh/D014453Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D002945Q000009 http://id.nlm.nih.gov/mesh/D005787 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D013274Q000235 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D013274Q000401 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006402Q000209 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D014057 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D002166Q000009 http://id.nlm.nih.gov/mesh/D054796 http://id.nlm.nih.gov/mesh/D002166Q000627 http://id.nlm.nih.gov/mesh/D000077146 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D020641 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9305 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60838 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a06a1e7ab201e03825d6bd6804b55722 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID54658

Total number of triples: 65.